创模生物科技(北京)有限公司

CN / En

NEWS

InnoModels Biotechnology: What are the advantages of SCID mouse NK drug efficacy model?

  • Categories:Company news
  • Author:InnoModels
  • Origin:InnoModels
  • Time of issue:2024-03-18 15:24
  • Views:

(Summary description)With the rapid development of the biomedical field, the demand for new drug development has become increasingly urgent. In this context, the SCID mouse NK pharmacodynamic model of InnoModels Biotechnology has become an indispensable tool for new drug discovery and development by virtue of its unique advantages. In this paper, we will introduce the characteristics of the SCID mouse NK pharmacodynamic model and its application value in drug discovery and development.

InnoModels Biotechnology: What are the advantages of SCID mouse NK drug efficacy model?

(Summary description)With the rapid development of the biomedical field, the demand for new drug development has become increasingly urgent. In this context, the SCID mouse NK pharmacodynamic model of InnoModels Biotechnology has become an indispensable tool for new drug discovery and development by virtue of its unique advantages. In this paper, we will introduce the characteristics of the SCID mouse NK pharmacodynamic model and its application value in drug discovery and development.

  • Categories:Company news
  • Author:InnoModels
  • Origin:InnoModels
  • Time of issue:2024-03-18 15:24
  • Views:
Information

With the rapid development of the biomedical field, the demand for new drug development has become increasingly urgent. In this context, the SCID mouse NK pharmacodynamic model of InnoModels Biotechnology has become an indispensable tool for new drug discovery and development by virtue of its unique advantages. In this paper, we will introduce the characteristics of the SCID mouse NK pharmacodynamic model and its application value in drug discovery and development.
Overview of the SCID mouse NK pharmacodynamic model
SCID mice (severe combined immunodeficiency mice) are an animal model of innate immune system defects with extremely low T and B cell immunity. And NK cells (natural killer cells), as an important part of the immune system, have a variety of functions such as antiviral, anti-tumor and immunomodulation. Combining SCID mice with NK cells to construct the SCID mouse NK drug efficacy model can mimic the response of the human immune system in specific disease states and provide powerful support for new drug development.
Advantages of SCID Mouse NK Efficacy Model
1. Highly simulate the human immune system: The SCID mouse NK efficacy model can simulate the response of the human immune system in specific disease states, providing a test environment closer to the actual one for new drug development. This helps researchers to identify potential safety risks at the early stage of new drug development and improve the success rate of drug development.
2. High sensitivity: Due to the defective immune system of SCID mice, NK cells play a crucial role in the evaluation of new drug efficacy. Therefore, the SCID mouse NK efficacy model has high sensitivity in the assessment of new drug efficacy, which helps to discover drugs with potential efficacy.
3. Reproducibility: The SCID mouse NK pharmacodynamic model has a stable genetic background and controllable experimental conditions, which makes the experimental results highly reproducible. This facilitates data accumulation and comparative analysis in the process of new drug development.
4. Wide application: The SCID mouse NK efficacy model can be used to evaluate the efficacy of many types of drugs, such as antiviral drugs, antitumor drugs and immunomodulatory drugs. This makes the model has a wide range of applications in the field of new drug development.

 


Application of SCID mouse NK efficacy model in new drug development
1. Drug screening: Using the SCID mouse NK pharmacodynamic model, researchers can quickly screen a large number of drug candidates and discover drugs with potential efficacy. This helps to shorten the cycle of new drug development and reduce R&D costs.
2. Drug efficacy evaluation: The SCID mouse NK efficacy model can be used to evaluate the efficacy of new drugs in different disease states, providing powerful support for drug development. By comparing the efficacy of different drugs in different disease states, researchers can select the most promising drugs for in-depth study.
3. Drug action mechanism research: SCID mouse NK efficacy model can also be used to study the mechanism of action of new drugs. By observing the changes in the efficacy of new drugs in the model, researchers can gain an in-depth understanding of the interaction between drugs and the immune system, providing a theoretical basis for drug development.
Summary
With its advantages of highly simulating the human immune system, high sensitivity, reproducibility and wide application, the SCID mouse NK efficacy model of InnoModels Biotechnology has become an important tool in the field of new drug research and development. By utilizing this model, researchers can quickly screen out drugs with potential therapeutic effects, assess drug efficacy, and study drug action mechanisms in depth, providing powerful support for the development and application of new drugs. With the continuous development of the biomedical field, the SCID mouse NK efficacy model will play an even more important role in the future development of new drugs.

Keyword:

In the vast field of oncology and tumor immunopharmacodynamics research, InnoModels Biotechnology (Beijing) Ltd. has become a leader in the industry with its outstanding innovation ability and profound scientific research background. This company, co-founded by scientists from Novo Nordisk China R&D Center, Sino-US Crown and Shanghai Jiao Tong University Institute of Immunology, has been committed to building a stable domestic platform of humanized mouse models of the immune system (HIS) and human tumor xenografts (PDX) since its establishment in 2020, to provide new drug discovery and development companies, translational medicine researchers, and tumor patients with new-generation laboratory animal models for new drug discovery companies, translational medicine researchers, and tumor patients
In recent years, many breakthroughs have been made in the field of biomedical research, among which iHuPBMC-T technology is undoubtedly a shining star. As an innovative platform built by InnoModels Biotechnology (Beijing) Co., Ltd, iHuPBMC-T, with its unique technological advantages, shows great potential in optimizing the reconstruction of human peripheral blood single nucleated cell (PBMC) model and immuno-oncology research.
Recently, InnoModels Biotechnology (Beijing) Co., Ltd. has made a major breakthrough in the field of pharmaceutical technology, and successfully obtained a patent entitled “Method and application for the detection of immune system rebuilding ability of PBMC”. This patent not only adds a new footnote to the R&D strength of InnoModels Biotechnology in the field of biomedicine, but also provides a strong technical support for the promotion of drug research and development and the establishment of humanized experimental animal models
With the rapid development of biotechnology, the in-depth study of the immune system has become the key to new drug discovery, disease diagnosis and treatment. InnoModels Bio-technology (Beijing) Co., Ltd. provides strong support for researchers with its profound scientific background and advanced technology platform. Among them, the ELISpot platform of InnoModels Biotechnology has made a name for itself in the field of immunology research with its high sensitivity and multi-functionality
InnoModels' ADCC platform plays a pivotal role in advancing cancer treatment, and its unique technological advantages and innovative concepts have brought about a far-reaching impact on the field of tumor immunotherapy. The following is a detailed introduction of how the platform promotes the advancement of cancer treatment
In the field of tumor immunotherapy, complement-dependent cytotoxicity (CDC), as an important therapeutic mechanism, is gradually showing its great potential and value. In order to explore this mechanism more deeply, with its profound accumulation in the field of oncology and tumor immunopharmacodynamics CRO services, InnoModels Biotechnology (Beijing) Co., Ltd. has launched the CDC in vitro immune-tumor cell co-culture killing experimental platform, which provides researchers with a powerful and precise tool to help innovate cancer treatment
Previous page
1
2
43
  • Tel 15010000264
  • E-mail limy@imodels.tech
  • Tel 13810723384
  • Top

InnoModels Biotechnology (Beijing) Co., Ltd.

TEL:15010000264        13810723384

Address:Building 14, Life Valley, Shuangying West Road, Changping District, Beijing

Chuangmo Biotechnology (Beijing) Co., Ltd. Beijing ICP 222*** 98-1 Website Construction: China Enterprise Power Beijing Second Branch Company

北京中因科技有限公司

创模生物科技(北京)有限公司